Artelo Biosciences shareholders approve increase in authorized shares and share issuance at 2026 annual meeting

ARTELO BIOSCIENCES, INC.

Three Class III directors re-elected: Reyes (179,416 for), Favorito (176,821), Gorgas (171,567); broker non-votes 937,382.
Amendment to increase authorized common stock from 166,666,667 to 500,000,000 approved: 985,717 for, 164,845 against, 21,641 abstain.
Share issuance >20% under Equity Purchase Agreement with Square Gate Capital Master Fund approved: 91,158 for, 65,155 against, 78,508 abstain, 937,382 broker non-votes.
Approximately 41.2% of outstanding shares (1,172,203 of 2,848,540) represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.